Literature DB >> 9116997

Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi.

A J Ammit1, S S Bekir, P R Johnson, J M Hughes, C L Armour, J L Black.   

Abstract

The aim of this study was to examine the process underlying the increase in responsiveness of human bronchus related to sensitization status by examining inflammatory cells in sensitized and nonsensitized tissue. Sensitization status was determined in tissue from 26 subjects by detecting the presence or absence of contraction of bronchial rings to common Australian allergens. Serial sections (6-micron) of bronchial tissue were stained for mast cells, T lymphocytes, and eosinophils. There was no significant difference between the total number of inflammatory cells present in all locations (to a depth of 0.5 mm) of nonsensitized (n = 14) and sensitized (n = 12) bronchi. Similar numbers of cells were present in the two patient groups in epithelium, lamina propria, and adventitia. In contrast, there were significantly (p = 0.03) more inflammatory cells present within the smooth muscle of sensitized bronchi. A significantly (p = 0.04) greater number of mast cells in sensitized (9 [2-14]) versus nonsensitized (2[0-8]) tissue was found in this location (data are median with first and third quartile range). In addition there was a trend toward a greater area of smooth muscle in sensitized tissue. There results suggest that an interaction between smooth muscle and inflammatory cells, especially mast cells, may play a role in bronchial hyperresponsiveness in vitro.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9116997     DOI: 10.1164/ajrccm.155.3.9116997

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  14 in total

Review 1.  Peripheral airways in asthma.

Authors:  Alan L James
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

Review 2.  Airway smooth muscle in the pathophysiology and treatment of asthma.

Authors:  Diana C Doeing; Julian Solway
Journal:  J Appl Physiol (1985)       Date:  2013-01-10

Review 3.  Mast cell progenitor trafficking and maturation.

Authors:  Jenny Hallgren; Michael F Gurish
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 4.  Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.

Authors:  Sanjiv Sharma; Adam Jaffe; Garth Dixon
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

5.  Inhibition by glucocorticoids of the interleukin-1beta-enhanced expression of the mast cell growth factor SCF.

Authors:  Carla Alexandra Da Silva; Olivier Kassel; Eric Mathieu; Gilbert Massard; Bernard Gasser; Nelly Frossard
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma.

Authors:  N G Carroll; S Mutavdzic; A L James
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

7.  Heparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle.

Authors:  V Kanabar; C P Page; D E Simcock; C Karner; K Mahn; B J O'Connor; S J Hirst
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

Review 8.  Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future.

Authors:  Sandra D Anderson; John D Brannan
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 9.  The re-emergence of the mast cell as a pivotal cell in asthma pathogenesis.

Authors:  Christopher E Brightling; Peter Bradding
Journal:  Curr Allergy Asthma Rep       Date:  2005-03       Impact factor: 4.919

10.  The pivotal role of airway smooth muscle in asthma pathophysiology.

Authors:  Annaïg Ozier; Benoit Allard; Imane Bara; Pierre-Olivier Girodet; Thomas Trian; Roger Marthan; Patrick Berger
Journal:  J Allergy (Cairo)       Date:  2011-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.